Stock AIM AIM IMMUNOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart AIM ImmunoTech Inc.

Equities

AIM

US00901B1052

Market Closed - Nyse
Other stock markets
 04:10:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
0.4 USD -8.38% Intraday chart for AIM ImmunoTech Inc. -1.19% -9.07%
Apr. 29 AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed MT
Apr. 10 AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
AIM IMMUNOTECH INC.
Bio Therapeutic Drugs
-8.38%-1.19%-9.07%-14.88%-93.94% 19.96M
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. AIM Stock
  4. Charts AIM ImmunoTech Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW